Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque.

Walker LM, Sok D, Nishimura Y, Donau O, Sadjadpour R, Gautam R, Shingai M, Pejchal R, Ramos A, Simek MD, Geng Y, Wilson IA, Poignard P, Martin MA, Burton DR.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20125-9. doi: 10.1073/pnas.1117531108. Epub 2011 Nov 28.

2.

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.

Ruprecht RM, Hofmann-Lehmann R, Smith-Franklin BA, Rasmussen RA, Liska V, Vlasak J, Xu W, Baba TW, Chenine AL, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Montefiori DC, McClure HM.

Transfus Clin Biol. 2001 Aug;8(4):350-8. Review.

PMID:
11642027
4.

Fc receptor-mediated antiviral antibodies.

Forthal DN, Moog C.

Curr Opin HIV AIDS. 2009 Sep;4(5):388-93. doi: 10.1097/COH.0b013e32832f0a89. Review.

5.

Broadly Neutralizing Antibodies for HIV Eradication.

Stephenson KE, Barouch DH.

Curr HIV/AIDS Rep. 2016 Feb;13(1):31-7. doi: 10.1007/s11904-016-0299-7. Review.

6.

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection.

Derdeyn CA, Moore PL, Morris L.

Curr Opin HIV AIDS. 2014 May;9(3):210-6. doi: 10.1097/COH.0000000000000057. Review.

7.

The HIV glycan shield as a target for broadly neutralizing antibodies.

Doores KJ.

FEBS J. 2015 Dec;282(24):4679-91. doi: 10.1111/febs.13530. Epub 2015 Oct 23. Review.

8.

The dysfunction of T follicular helper cells.

Cubas R, Perreau M.

Curr Opin HIV AIDS. 2014 Sep;9(5):485-91. doi: 10.1097/COH.0000000000000095. Review.

9.

Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization.

Yamamoto H, Matano T.

Front Microbiol. 2016 Nov 2;7:1739. eCollection 2016 Nov 2. Review.

10.

Progress in HIV-1 vaccine development.

Haynes BF, McElrath MJ.

Curr Opin HIV AIDS. 2013 Jul;8(4):326-32. doi: 10.1097/COH.0b013e328361d178. Review.

11.

Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.

Bonsignori M, Liao HX, Gao F, Williams WB, Alam SM, Montefiori DC, Haynes BF.

Immunol Rev. 2017 Jan;275(1):145-160. doi: 10.1111/imr.12509. Review.

12.

Novel Imaging Methods for Analysis of Tissue Resident Cells in HIV/SIV.

Moysi E, Estes JD, Petrovas C.

Curr HIV/AIDS Rep. 2016 Feb;13(1):38-43. doi: 10.1007/s11904-016-0300-5. Review.

PMID:
26830285
13.

Host controls of HIV broadly neutralizing antibody development.

Kelsoe G, Haynes BF.

Immunol Rev. 2017 Jan;275(1):79-88. doi: 10.1111/imr.12508. Review.

PMID:
28133807
14.

Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.

Brady JM, Baltimore D, Balazs AB.

Immunol Rev. 2017 Jan;275(1):324-333. doi: 10.1111/imr.12478. Review.

PMID:
28133808
15.

Harnessing the protective potential of HIV-1 neutralizing antibodies.

Smith SA, Derdeyn CA.

F1000Res. 2016 Jan 5;5. pii: F1000 Faculty Rev-20. doi: 10.12688/f1000research.7254.1. eCollection 2016 Jan 5. Review.

16.

Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.

Verkoczy L, Alt FW, Tian M.

Immunol Rev. 2017 Jan;275(1):89-107. doi: 10.1111/imr.12505. Review.

PMID:
28133799
17.

Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.

Kepler TB, Wiehe K.

Immunol Rev. 2017 Jan;275(1):129-144. doi: 10.1111/imr.12513. Review.

PMID:
28133793
18.

Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.

Wu X, Kong XP.

Curr Opin Immunol. 2016 Oct;42:56-64. doi: 10.1016/j.coi.2016.05.013. Epub 2016 Jun 10. Review.

PMID:
27289425
19.

Polyvalent vaccine approaches to combat HIV-1 diversity.

Korber B, Hraber P, Wagh K, Hahn BH.

Immunol Rev. 2017 Jan;275(1):230-244. doi: 10.1111/imr.12516. Review.

PMID:
28133800

Supplemental Content

Support Center